Insight Molecular Diagnostics Inc. (OCX)
NASDAQ
3.28
-0.18 (-5.20%)
Closed
Oct 8, 2026
Day's Range
3.133.54
52 wk Range
2.428.51
Financial Statements - OCX - Insight Molecular Diagnostics Inc.
Revenue
1.88M▲ 25.1%
Net Income
-60.66M▼ 118.4%Net Margin -3225.0%
EBITDA
-21.22M▼ 4.3%
Free Cash Flow
-21.22M▲ 10.1%
Income Statement
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.88M | 1.50M | 958K | 2.19M | 1.21M | 0 |
| Cost of Goods | 1.14M | 1.09M | 976K | 778K | 1.85M | 0 |
| Gross Profit | 740K | 413K | -18K | 1.42M | -639K | 0 |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -23.24M | -22.41M | -28.85M | -24M | -33.72M | -22.23M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -37.33M | -2.38M | 10.32M | -28.65M | 2.78M | -486K |
| Pre Tax Income | -60.66M | -24.85M | -18.61M | -52.87M | -31.18M | -22.42M |
| Income Tax | - | - | 0 | -9.26M | -1.25M | 0 |
| Net Income | -60.66M | -27.78M | -72.90M | -64.09M | -29.93M | -22.42M |
| EPS Basic | -4.66 | -3.75 | -20 | -14.4 | -9.2 | -8.8 |
| EPS Diluted | -4.66 | -3.75 | -20 | -14.4 | -9.2 | -8.8 |
| Basic Shares Outstanding | 13.07M | 7.65M | 5.54M | 4.44M | 3.27M | 2.56M |
| Diluted Shares Outstanding | 13.07M | 7.65M | 5.54M | 4.44M | 3.27M | 2.56M |
| Ebit | -60.57M | -24.80M | -18.52M | -52.66M | -30.93M | -22.23M |
| Ebitda | -21.22M | -20.34M | -23.69M | -20.10M | -34.84M | -21.68M |
| Net Income Continuous Operations | -60.66M | -27.78M | -72.90M | -64.09M | -29.93M | -22.42M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | 520K | 0 | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
